Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-06-07 @ 3:59 AM
Study NCT ID:
NCT01309633
Status:
COMPLETED
Last Update Posted:
2019-07-22
First Post:
2011-03-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)
Sponsor:
National University Hospital, Singapore
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NP01/27/10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None